All stories tagged :

Pr Newswire

LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”

admin
Pr Newswire

MAIA Biotechnology Announces $736,600 Private Placement

admin
Pr Newswire

Geron Corporation Announces Executive Leadership Transitions and Appointments

admin
Pr Newswire

Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership...

admin
Pr Newswire

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

admin
Pr Newswire

NABR Comment on IUCN Determination

admin
Pr Newswire

J&T Express Q3 Parcel Volume Surges 23.1% YoY, Driven by 78.7%...

admin
Pr Newswire

Compass, the revolutionary application that aims to reduce the risk of...

admin
Pr Newswire

Green Street Brings Its Industry-Leading Public Market Research and REIT Data...

admin
Pr Newswire

/C O R R E C T I O N —...

admin
Pr Newswire

Evaxion to present a breadth of data from phase 2 trial...

admin

Featured

Pr Newswire

Geron Corporation Announces Executive Leadership Transitions and Appointments

admin
Pr Newswire

MAIA Biotechnology Announces $736,600 Private Placement

admin
Pr Newswire

Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership...

admin
Pr Newswire

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

admin
admin

Geron Corporation Announces Executive Leadership Transitions and Appointments

Four new executives appointed, including new Chief Commercial Officer, to lead commercial strategy and operationsFOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced several executive transitions...